Arbutamine
As of the edition of 20 October 2026, Arbutamine is a small molecule: marketed, first approved in 1997 (US); acts on ADRB1; no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1997
- Kind
- Small molecule
- Brand name
- Genesa
- First approved
- 12 September 1997 (US)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Gensia Automedics
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| ADRB1 | Beta-1 adrenergic receptor | P08588 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Gensia Automedics | Applicant | 1997 to now |